Caribou Biosciences (CRBU)’s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street
On February 2, 2026, Clear Street began covering Caribou Biosciences, Inc. (NASDAQ:CRBU) with a ‘Buy’ rating and a $13 price target.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Kynam Capital Derrick Tang | 2,503,302 | $3,980,250 | -19% | 0.25% |
| 2. | Renaissance Technologies Jim Simons | 1,639,857 | $2,607,373 | +111% | 0% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 1,115,700 | $1,773,963 | -10% | 0% |
| 4. | Partner Fund Management Christopher Medlock James | 957,787 | $1,522,881 | -30% | 0.15% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 881,105 | $1,400,957 | +601% | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.02 | 20,000 | $20,400.00 | 3,369,395 | 2025-03-14 | Filing | |
| $1.42 | 17,360 | $24,651.20 | 17,360 | 2025-01-29 | Filing | |
| $4.11 | 6,818 | $28,021.98 | 109,082 | 2022-01-11 | Filing | |
| $2.69 | 569 | $1,530.61 | 102,264 | 2022-01-11 | Filing | |
| $2.69 | 1,136 | $3,055.84 | 101,695 | 2021-12-20 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.35 | 3,564 | $4,811.40 | 443,502 | 2025-02-21 | Filing | |
| $1.35 | 3,564 | $4,811.40 | 66,936 | 2025-02-21 | Filing | |
| $1.35 | 3,564 | $4,811.40 | 431,556 | 2025-02-21 | Filing | |
| $6.31 | 5,627 | $35,506.37 | 59,373 | 2023-01-19 | Filing | |
| $10.80 | 10,000 | $107,958.00 | 110,366 | 2022-10-06 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,690,431 | $7,457,785 | 3.15% | |
| 2. | 4,304,198 | $6,843,676 | 0% | |
| 3. | 2,141,023 | $3,404,227 | 0% | |
| 4. | 1,388,905 | $2,208,359 | 0% | |
| 5. | 1,031,375 | $1,639,887 | 0% |